Abstract
In vitro antibacterial activity of new derivatives of pyridonecarboxylic acid, norfloxacin (NFLX), ofloxacin (OFLX), enoxacin (ENX) and ciprofloxacin (CPFX), against Vibrio cholerae O-1 was investigated. A total of 253 V. cholerae O-1 strains of different geographical origin, including 177 sensitive strains and 76 resistant strains to CP, TC, SM, KM, AP or ST, were submitted to the test for their minimum inhibitory concentrations (MICs) by standard agar dilution method.Growth of all the strains tested was inhibited by NFLX, OFLX, ENX and CPFX at the concentration of 0.2μg/ml or below. The MICs of these antibiotic agents were considerably lower than those of nalidixic acid, chloramphenicol, tetracycline, streptomycin, kanamycin, ampicillin and trimethoprimsulfamethoxazole, and distributed between 0.1 and ≤0.013μg/ml for NFLX and OFLX, 0.2 and 0.025μg/ml for ENX, and 0.025 and ≤0.013μg/ml for CPFX, regardless of serotype, source, year of isolation, or sensitivity to the other antibacterial drugs than these pyridonecarboxylic acid derivatives of test strains.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.